Regulation note: No peptide in the "recovery" space is currently a TGA-approved medicine in Australia for a recovery indication. Discussion is not the same as approval.
Body Protection Compound
A synthetic peptide commonly discussed in the context of tissue and tendon recovery.
Read entryThymosin Beta-4 fragment
A synthetic fragment of the Thymosin Beta-4 protein, commonly discussed alongside BPC-157 in recovery contexts.
Read entryImmune-modulating peptide
An immune-modulating peptide approved as a medicine in some overseas markets.
Read entryRecombinant human growth hormone
Recombinant human growth hormone, a registered medicine for defined indications.
Read entryMyostatin-binding protein
A protein discussed in muscle and metabolic research contexts.
Read entryLong-acting IGF-1 analogue
A long-acting analogue of insulin-like growth factor-1.
Read entryAnti-inflammatory tripeptide
A short peptide fragment (lysine-proline-valine) studied for anti-inflammatory effects, including in the gut.
Read entryThymic peptide
A thymus-derived peptide involved in immune regulation, studied in research settings.
Read entryThis is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.